Physician profile
Joshua Lim
NPI 1770878993
$13,070.89
in general payments reported to CMS, 2019-2025
31 companies · $638 in 2025
The $638 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,692 · 2020: $892 · 2021: $558 · 2022: $1,648 · 2023: $1,539 · 2024: $2,105 · 2025: $638.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,670 · Travel and Lodging: $611.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,670.00 |
| Travel and Lodging | $611.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,148.39 | 2021-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System, General - Pain Management |
| Stryker Corporation | $1,856.65 | 2019-2024 | Spinejack, Optablate |
| Synthes Gmbh | $1,730.52 | 2019 | |
| Si-Bone, INC. | $1,297.80 | 2019-2025 | |
| Medtronic USA, INC. | $1,177.95 | 2019 | |
| Medtronic, INC. | $936.68 | 2021-2025 | Cd Horizon Spinal System, Inceptiv, Intellis Adaptivestim |
| Globus Medical, INC. | $728.32 | 2019-2025 | Altera, Coalition Mis / Mis Ti, Rise |
| Nevro Corp. | $530.03 | 2022-2024 | Senza |
| Abbott Laboratories | $462.87 | 2020-2023 | Octrode, Eterna |
| Cerapedics INC. | $150.21 | 2022 | |
| Spinal Simplicity, LLC | $146.54 | 2024 | Ha Minuteman G3-R |
| Vertos Medical, INC. | $124.25 | 2023 | Mild Device Kit |
| Intrinsic Therapeutics | $100.51 | 2021-2023 | Barricaid Acd (Annular Closure Device) |
| Integra Lifesciences Corporation | $95.24 | 2019-2024 | Codman Certas, Cusa Clarity, Duraseal Exact Spinal Sealant System |
| Xtant Medical INC | $61.68 | 2023 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Theragen, INC. | $60.14 | 2022-2025 | Actastim-S |
| Orthofix Medical, INC. | $57.54 | 2020-2022 | |
| Spineology INC. | $52.45 | 2022 | |
| Providence Medical Technology, INC. | $52.13 | 2021 | |
| Arteriocyte Medical Systems, INC. | $36.68 | 2021-2022 | |
| Spine Wave, INC. | $36.50 | 2025 | Spinal Implant, Annex Adjacent Level System |
| Surgalign Spine Technologies, INC. | $31.57 | 2021 | |
| Misonix INC | $30.46 | 2021 | |
| Longeviti Neuro Solutions INC | $28.41 | 2025 | Clearfit |
| Baxter Healthcare | $26.82 | 2020 | |
| Supreme Orthopedic Systems, LLC | $23.73 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $23.31 | 2023 | Exparel |
| Augmedics INC. | $18.91 | 2024 | Xvision |
| Astrazeneca Pharmaceuticals LP | $18.90 | 2023 | Andexxa |
| Arbor Pharmaceuticals, INC. | $14.16 | 2021 | |
| Kuros Biosciences USA, INC | $11.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Lim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.